The FDA Just Rejected a Bid for MDMA’s Approval to Treat PTSD
1 year ago
54
ARTICLE AD BOX
The regulatory agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder.